ImmunityBio Inc. (IBRX) has been drawing attention in recent sessions, with its shares showing notable momentum and fresh regulatory developments adding to the narrative. The company's focus on next-gen immunotherapies positions it at the intersection of oncology innovation and commercial growth.About ImmunityBioImmunityBio is a commercial-stage biotechnology company developing therapies that stre...
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.